| 1. | | Recruiting | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer |
| 2. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 3. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 4. | | Not yet recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 5. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome |
| 6. | | Recruiting | 17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease; Kidney Cancer |
| 7. | | Recruiting | A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
Condition: Prostatic Hyperplasia |
| 8. | | Not yet recruiting | 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 9. | | No longer recruiting | 3-AP in Treating Patients With Advanced Prostate Cancer
Conditions: recurrent prostate cancer; stage IV prostate cancer |
| 10. | | Recruiting | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
| 11. | | Completed | 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 12. | | Completed | 6-Hydroxymethylacylfulvene in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical adenocarcinoma; cervical squamous cell carcinoma; cervical adenosquamous cell carcinoma; ... |
| 13. | | No longer recruiting | ABT-510 in Treating Patients With Locally Recurrent or Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
| 14. | | No longer recruiting | ABT-751 in Treating Patients With Locally Recurrent or Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
| 15. | | Recruiting | ABT-751 in Treating Young Patients With Refractory Solid Tumors
Condition: childhood cancer |
| 16. | | Completed | ABX-EGF (a monoclonal antibody) Given to Patients with Prostate Cancer with or without Tumor in Other Parts of the Body
Condition: Prostate Cancer |
| 17. | | Completed | Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy |
| 18. | | Completed | Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity |
| 19. | | Terminated | Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity |
| 20. | | Recruiting | Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA
Condition: Renal Cell Carcinoma |
| 21. | | Recruiting | Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
Condition: Interstitial Cystitis |
| 22. | | Not yet recruiting | Acupuncture for Women's Health Conditions
Conditions: Ovarian Neoplasms; Endometriosis; Pelvic Pain; Uterine Neoplasms |
| 23. | | Recruiting | Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy; Pain |
| 24. | | No longer recruiting | Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
Condition: Ovarian Cancer |
| 25. | | Completed | AD 32 Alone or With BCG Following Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
Conditions: stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer |
| 26. | | No longer recruiting | Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer |
| 27. | | Recruiting | Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 28. | | Recruiting | Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Conditions: stage III prostate cancer; stage II prostate cancer |
| 29. | | Recruiting | Advanced Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell; Kidney Neoplasms |
| 30. | | Recruiting | AG-013736 as Second-Line Therapy in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 31. | | Recruiting | Allogeneic Stem Cell Transplantation in Treating Patients With Metastatic Renal Cell Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 32. | | No longer recruiting | Alternate Day Prednisone or Daily Fish Oil Supplements in Patients with Immunoglobulin A Nephropathy
Condition: IGA Glomerulonephritis |
| 33. | | Recruiting | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Condition: Prostate Cancer |
| 34. | | No longer recruiting | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Conditions: Lung Cancer; Ovarian Cancer; Lymphoma; Leukemia; Breast Cancer |
| 35. | | No longer recruiting | Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ... |
| 36. | | Recruiting | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Conditions: adult solid tumor; Breast Cancer; Lung Cancer; neurotoxicity; ovarian epithelial cancer; Prostate Cancer |
| 37. | | Recruiting | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
Conditions: Endocrine Cancer; female reproductive cancer; neurotoxicity |
| 38. | | Completed | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Conditions: Endometrial Cancer; ovarian epithelial cancer; Cervical Cancer; uterine sarcoma |
| 39. | | No longer recruiting | Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
Conditions: childhood soft tissue sarcoma; childhood liver cancer; adult soft tissue sarcoma; Bone Cancer; ovarian sarcoma; Testicular Cancer; Brain Tumor; ... |
| 40. | | Recruiting | Amifostine to Protect the Rectum during External Beam Radiotherapy for Prostate Cancer
Condition: Prostatic Neoplasms |
| 41. | | No longer recruiting | Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Gastrointestinal Cancer; Pancreatic Cancer; Liver Cancer; Female Reproductive Cancer |
| 42. | | Completed | Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 43. | | No longer recruiting | Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 44. | | No longer recruiting | Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer
Condition: recurrent ovarian epithelial cancer |
| 45. | | No longer recruiting | Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Condition: recurrent endometrial cancer |
| 46. | | Completed | Analysis of Bronchial Tissue and Fluid in Patients with Wegener's Granulomatosis
Conditions: Inflammation; Vasculitis; Wegener's Granulomatosis |
| 47. | | Completed | Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
Condition: Prostate Cancer |
| 48. | | Recruiting | Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer |
| 49. | | No longer recruiting | Androgens and Subclinical Atherosclerosis in Young Women - Ancillary to CARDIA
Conditions: Cardiovascular Diseases; Coronary Arteriosclerosis; Heart Diseases; Polycystic Ovary Syndrome |
| 50. | | Recruiting | Angiotensin II Blockade
Conditions: Kidney Disease; Proteinuria |
